EGFR Fusions as Novel Therapeutic Targets in Lung Cancer.

Konduri K, Gallant JN, Chae YK, Giles FJ, Gitlitz BJ, Gowen K, Ichihara E, Owonikoko TK, Peddareddigari V, Ramalingam SS, Reddy SK, Eaby-Sandy B, VavalĂ  T, Whiteley A, Chen H, Yan Y, Sheehan JH, Meiler J, Morosini D, Ross JS, Stephens PJ, Miller VA, Ali SM, Lovly CM
Cancer Discov. 2016 6 (6): 601-11

PMID: 27102076 · PMCID: PMC4893907 · DOI:10.1158/2159-8290.CD-16-0075

MeSH Terms (24)

Adult Antineoplastic Agents Biomarkers Cell Line, Tumor Combined Modality Therapy ErbB Receptors Exons Female Genetic Loci High-Throughput Nucleotide Sequencing Humans Introns Lung Neoplasms Magnetic Resonance Imaging Male Middle Aged Models, Molecular Molecular Targeted Therapy Neoplasm Metastasis Oncogene Proteins, Fusion Protein Conformation Protein Kinase Inhibitors Rad51 Recombinase Young Adult

Connections (4)

This publication is referenced by other Labnodes entities:

Links